REMISIN
REMISIN
Discontinued
DIN Number
00226033
Drug Class
Human
Market Date
Dec 31, 1972
Company
HC
dr reckeweg and co
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00226033
AIG Number0508570001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (5)
CALCIUM IODIDEActive
Strength: 12 X / X
Monograph: CALCIUM IODIDE
FERROUS IODIDEActive
Strength: 12 X / X
Monograph: FERROUS IODIDE
NITRIC ACIDActive
Strength: 12 X / X
Monograph: NITRIC ACID
PHOSPHORIC ACIDActive
Strength: 12 X / X
Monograph: PHOSPHORIC ACID
SULFUR IODIDEActive
Strength: 12 X / X
Monograph: SULFUR IODIDE